These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23360223)

  • 1. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease.
    Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Tsutsumida A; Otsuka F; Yamazaki N
    Br J Dermatol; 2013 Jun; 168(6):1259-66. PubMed ID: 23360223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of HER2 and TUBB3 proteins in extramammary Paget disease.
    Miyamoto A; Akasaka K; Oikawa H; Akasaka T; Masuda T; Maesawa C
    Am J Dermatopathol; 2010 Aug; 32(6):578-85. PubMed ID: 20534991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease.
    Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Takahashi A; Tsutsumida A; Fujisawa Y; Fujimoto M; Yamazaki N
    Clin Exp Metastasis; 2016 Oct; 33(7):687-97. PubMed ID: 27289366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of HER-2 in extramammary Paget's disease.
    Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
    Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.
    Hirai I; Tanese K; Nakamura Y; Otsuka A; Fujisawa Y; Yamamoto Y; Hata H; Fujimura T; Matsushita S; Yoshino K; Kameyama K; Amagai M; Funakoshi T
    Med Oncol; 2018 May; 35(6):92. PubMed ID: 29744813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 oncogene amplification in extramammary Paget's disease.
    Tanskanen M; Jahkola T; Asko-Seljavaara S; Jalkanen J; Isola J
    Histopathology; 2003 Jun; 42(6):575-9. PubMed ID: 12786893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein.
    Ogawa T; Nagashima Y; Wada H; Akimoto K; Chiba Y; Nagatani T; Inayama Y; Yao M; Aoki I; Ikezawa Z
    Hum Pathol; 2005 Dec; 36(12):1273-80. PubMed ID: 16311120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HER2 by chromogenic in situ hybridization and immunohistochemistry in lymph node-negative breast carcinoma: Prognostic relevance.
    Peiró G; Aranda FI; Adrover E; Niveiro M; Alenda C; Payá A; Seguí J
    Hum Pathol; 2007 Jan; 38(1):26-34. PubMed ID: 17056098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
    Cornolti G; Ungari M; Morassi ML; Facchetti F; Rossi E; Lombardi D; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy.
    Plaza JA; Torres-Cabala C; Ivan D; Prieto VG
    J Cutan Pathol; 2009 Jul; 36(7):729-33. PubMed ID: 19519604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget's disease.
    Hikita T; Ohtsuki Y; Maeda T; Furihata M
    Int J Surg Pathol; 2012 Oct; 20(5):441-8. PubMed ID: 23001873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study.
    Bianco MK; Vasef MA
    Diagn Mol Pathol; 2006 Sep; 15(3):131-5. PubMed ID: 16932067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
    Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
    Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unbiased Detection of Driver Mutations in Extramammary Paget Disease.
    Ishida Y; Kakiuchi N; Yoshida K; Inoue Y; Irie H; Kataoka TR; Hirata M; Funakoshi T; Matsushita S; Hata H; Uchi H; Yamamoto Y; Fujisawa Y; Fujimura T; Saiki R; Takeuchi K; Shiraishi Y; Chiba K; Tanaka H; Otsuka A; Miyano S; Kabashima K; Ogawa S
    Clin Cancer Res; 2021 Mar; 27(6):1756-1765. PubMed ID: 33323405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease.
    Takata M; Fujimoto A; Aoki H; Hatta N; Ooi A; Takehara K
    J Invest Dermatol; 1999 Aug; 113(2):258-62. PubMed ID: 10469313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
    Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K
    Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases.
    Hansel DE; Swain E; Dreicer R; Tubbs RR
    Am J Clin Pathol; 2008 Aug; 130(2):274-81. PubMed ID: 18628098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.